Wes,
A clue here for JCR penetration, can be found in JCR's own comments from a few years back.
July 31 - 2020
"JCR Pharmaceuticals Co., Ltd. to Expand the Manufacturing Area to Increase Production Capacity for TEMCELL HS Injection"
Medical institutions have highly rated TEMCELL® HS Inj. since its launch in 2016 and JCR has received orders far in excess of its initial forecasts"
"This expansion will raise the production capacity for TEMCELL® HS Inj. by about 30% over current levels, ensure an appropriate inventory and enable sufficient supply to meet the market's robust demand"
MSB recieved royalty revenue Jul19 - Jun20 of US 6.6 million. ( Pre JCR 30% increase in manufacturing )
MSB recieved royalty revenue Jul22 - Jun23 of US 7.48 million. ( Post Covid & JCR 30% increase in manufacturing )
Royalty Increase of 13%, however I suspect these results would have been heavily impacted by Covid in a multitude of ways.
If JCR manage 40 - 50% market penetration with lower survival than Ryoncil, I guess we will get higher penetration.
Wes, A clue here for JCR penetration, can be found in JCR's own...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |